Overview
- Develops the new concept of global catastrophic biological risks
- Reframes infectious disease and pandemic discussions in light of their risk of causing a catastrophe
- Shares new insights into the special characteristics of various microbes, as well as financing challenges
Part of the book series: Current Topics in Microbiology and Immunology (CT MICROBIOLOGY, volume 424)
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (8 chapters)
-
Front Matter
Keywords
About this book
This volume focuses on Global Catastrophic Biological Risks (GCBRs), a special class of infectious disease outbreaks or pandemics in which the combined capacity of the world’s private and government resources becomes severely strained. These events, of which the 1918 influenza pandemic is emblematic, cause severe disruptions in the normal functioning of the world, exact heavy tolls in terms of morbidity and mortality, and lead to major economic losses.
GCBRs can be caused by any type of microorganism, and myriad contextual factors can influence their impact. Additionally, there are cascading questions that arise in connection with GCBR prediction, preparation, and response.
This book gathers contributions from thought leaders who discuss the multi-faceted approaches needed in order to address this problem. From understanding the special characteristics of various microbes to financing challenges, the volume provides an essential primer on a neglected but highly relevant topic. Physicians, scientists, policymakers, public health practitioners and anyone with an interest in the field of pandemics, emerging infectious disease, biosecurity, and global health security will find it a valuable and insightful resource.
Editors and Affiliations
About the editors
Dr. Inglesby is the Director of the Center for Health Security of the Johns Hopkins Bloomberg School of Public Health. The Center for Health Security is dedicated to protecting people’s health from the consequences of epidemics and disasters. Dr. Inglesby is also a Professor in the Department of Environmental Health and Engineering in the Johns Hopkins Bloomberg School of Public Health, with a Joint Appointment in the Johns Hopkins School of Medicine. Dr. Inglesby's work is internationally recognized in the fields of public health preparedness, pandemic and emerging infectious disease, and prevention of and response to biological threats.
Dr. Adalja is a Senior Scholar at the Johns Hopkins University Center for Health Security. He is a board certified physician in internal medicine, emergency medicine, infectious diseases, and critical care medicine. He has served on US government panels tasked with developing guidelines for the treatment of plague, botulism and anthrax inmass casualty settings, the system of care for infectious disease emergencies, and as an external advisor to New York City Health and Hospital Emergency Management Highly Infectious Disease training program.
Bibliographic Information
Book Title: Global Catastrophic Biological Risks
Editors: Thomas V. Inglesby, Amesh A. Adalja
Series Title: Current Topics in Microbiology and Immunology
DOI: https://doi.org/10.1007/978-3-030-36311-6
Publisher: Springer Cham
eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)
Copyright Information: Springer Nature Switzerland AG 2019
Hardcover ISBN: 978-3-030-36310-9Published: 12 December 2019
Softcover ISBN: 978-3-030-36313-0Published: 12 December 2020
eBook ISBN: 978-3-030-36311-6Published: 28 November 2019
Series ISSN: 0070-217X
Series E-ISSN: 2196-9965
Edition Number: 1
Number of Pages: VII, 128
Number of Illustrations: 2 b/w illustrations, 6 illustrations in colour
Topics: Immunology, Health Promotion and Disease Prevention, Epidemiology, Infectious Diseases, Human Physiology, Vaccine